A significant advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently inactivated in various forms of https://sites2000.com/story11813027/vhh-fragments-restore-the-p53-protein-a-potential-pathway-for-tumor-management